Subscribe To
IPA / ImmunoPrecise Antibodies Ltd.'s (IPA) CEO Dr. Jennifer Bath on Q2 2022 Results - Earnings Call Transcript
IPA News
By Zacks Investment Research
March 16, 2023
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Lags Revenue Estimates
ImmunoPrecise Antibodies Ltd. (IPA) delivered earnings and revenue surprises of -16.67% and 6.19%, respectively, for the quarter ended January 2023. more_horizontal
By Business Wire
March 7, 2023
IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023 on March 16, 2023
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an advan more_horizontal
By Seeking Alpha
December 15, 2022
ImmunoPrecise Antibodies Ltd. (IPA) Q2 2023 Earnings Call Transcript
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q2 2023 Earnings Conference Call December 15, 2022 10:30 AM ET Company Participants Jennifer Bath – Chie more_horizontal
By Business Wire
December 5, 2022
IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023 on December 15, 2022
VICTORIA, British Columbia--( BUSINESS WIRE )--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an advanced biother more_horizontal
By Business Wire
July 26, 2022
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2022 on July 29, 2022
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IP more_horizontal
By Seeking Alpha
March 16, 2022
ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q3 2022 Results - Earnings Call Transcript
ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q3 2022 Results - Earnings Call Transcript more_horizontal
By Business Wire
March 8, 2022
ImmunoPrecise Sets Third Quarter Fiscal 2022 Financial Results and Recent Business Highlights Conference Call for Wednesday, March 16th at 10:30 a.m. ET
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: more_horizontal
By Benzinga
January 31, 2022
ImmunoPrecise's COVID-19 Antibody Cocktail Shows Neutralization Activity Against Omicron
Immunoprecise Antibodies Ltd IPA has released preclinical data for the PolyTope TATX-03 COVID-19 antibody cocktail. [ALERT] Nic Chahine shares his Be more_horizontal
